Goosefoot Allergy: The Amaranthaceae Weed Pollen Family and What It Means
Goosefoot (Chenopodium genus, Amaranthaceae) is a true wind-pollinated aeroallergen family with well-characterized pollen proteins from its most studied species, lamb's quarters (C. album). The marker allergen Che a 1 shows 77 percent sensitization in chenopod-allergic patients. Over 150 Chenopodium species exist worldwide. Cross-reactivity within Amaranthaceae is extensive. Sublingual immunotherapy is directly indicated for confirmed Chenopodium pollen sensitization. Immunotherapy targets the primary sensitizing species.
Free · 5 min · Insurance accepted
Key facts
Che a 1, an Ole e 1-like glycoprotein from Chenopodium album, is recognized by 77% of sensitized patients and serves as the primary marker allergen for Chenopodium sensitization.
Chenopodium and Amaranthus pollen grains are morphologically indistinguishable under standard light microscopy — most pollen counting stations report them as a combined Chenopodiaceae/Amaranthaceae category.
Goosefoot pollen season (July–October) coincides with ragweed season, creating additive allergen exposure in sensitized patients — approximately 9% of allergic populations show SPT positivity.
Despite structural homology between Che a 1 and olive Ole e 1, their clinical cross-reactivity is low — co-positivity more often reflects genuine dual sensitization than cross-reactive IgE.
Bousquet et al., Practical guide to skin prick tests, Allergy, 2012
What Is Goosefoot Allergy?

Goosefoot is the common name for the genus Chenopodium in the Amaranthaceae family (formerly classified separately as Chenopodiaceae).
With over 150 species distributed worldwide, Chenopodium encompasses some of the most common weeds in gardens, agricultural fields, and disturbed ground across the United States. The genus includes lamb's quarters (C. album) — one of the world's most ubiquitous weeds — as well as the cultivated food crop quinoa (C. quinoa).
All Chenopodium species of allergenic importance are wind-pollinated, producing abundant lightweight pollen that becomes airborne during late summer through fall. The allergen profile is well-characterized through studies of C. album: three WHO/IUIS-listed allergens have been identified, with Che a 1 (an Ole e 1-like glycoprotein) serving as the marker allergen for primary chenopod sensitization at 77 percent reactivity among allergic patients.
This page serves as the genus-level overview for goosefoot allergy. Patients who know their specific species (lamb's quarters, fat hen, white goosefoot) may find the species-level page more targeted. For those who encounter Chenopodium weeds but cannot identify the exact species — which is common given that Chenopodium and Amaranthus pollen grains are morphologically indistinguishable under light microscopy — this page covers the genus-wide clinical picture.
The Chenopodium genus has undergone significant taxonomic revision in recent decades. Many species formerly placed in the family Chenopodiaceae are now classified within Amaranthaceae based on molecular phylogenetic evidence. This reclassification has practical implications for allergy: Chenopodium (goosefoot), Amaranthus (pigweed), Salsola (Russian thistle), Bassia (kochia), and Atriplex (saltbush) are all now recognized as Amaranthaceae members with extensive pollen cross-reactivity. Understanding this family relationship helps explain why patients sensitized to one genus frequently react to several others on allergy testing panels.
Goosefoot Allergy Symptoms
Recognizing symptoms early helps you get the right treatment faster.
Sneezing
moderateRepetitive sneezing triggered by Chenopodium pollen inhalation, often in bursts upon initial outdoor exposure during fall pollen season.
Nasal congestion
moderateStuffy nose from mucosal edema in the late-phase allergic response, often worse in the morning after overnight pollen accumulation.
Rhinorrhea (runny nose)
moderateClear, watery nasal discharge from histamine-driven mucus production in the nasal mucosa.
Itchy, watery eyes
moderateAllergic conjunctivitis from pollen deposition on the conjunctival surface, causing IgE-mediated mast cell activation.
Asthma exacerbation
moderateWheezing, chest tightness, and coughing in patients with pre-existing asthma when Chenopodium pollen triggers bronchial inflammation.
When to see a doctor
Goosefoot pollen allergy produces the classic rhinoconjunctivitis syndrome: sneezing, nasal congestion, runny nose, and itchy watery eyes during the late summer through fall pollen season. For sensitized patients with concurrent asthma, Chenopodium pollen exposure can trigger bronchospasm and asthma exacerbations. Symptoms may be difficult to distinguish from ragweed allergy because the seasons overlap extensively. Many patients with fall hay fever have concurrent sensitization to multiple fall weed pollens (ragweed, Chenopodium, mugwort) and experience a composite symptom burden. Comprehensive allergen testing is needed to parse out the individual contributions. A distinctive feature of Chenopodium pollen allergy that helps differentiate it from ragweed sensitization is the timing of symptom onset within the fall season. While ragweed symptoms often peak sharply in mid-September and decline by early October, Chenopodium symptoms may begin earlier in July and persist more steadily through October. Patients who notice that their fall symptoms start before ragweed pollen counts rise, or who experience a broader plateau of symptoms rather than a sharp peak, may have a significant Chenopodium component. Symptom diary correlation with the combined Chenopodiaceae/Amaranthaceae pollen category in local forecasts is more informative than tracking ragweed counts alone.
Goosefoot Pollen and Asthma
Chenopodium pollen is associated with allergic asthma in sensitized individuals. The Amaranthaceae family as a whole — including Russian thistle, which is specifically linked to severe disabling asthma in the western US — represents a significant fall asthma trigger group. For patients with fall-onset or fall-worsening asthma, testing for Amaranthaceae pollen sensitization (including Chenopodium) is clinically important. Effective asthma management during the Chenopodium season may require a combination of controller medications, pollen avoidance, and consideration of immunotherapy for the underlying sensitization.
Complications of Untreated Goosefoot Allergy
Untreated Chenopodium pollen allergy follows the same complication trajectory as other chronic allergic rhinitis: reduced quality of life, sleep disruption from nasal congestion, decreased productivity during the fall season, and — critically — potential progression to allergic asthma (the allergic march). Chronic nasal inflammation can also predispose to sinusitis and secondary infections. The sleep disruption caused by chronic nasal congestion during the four-month Chenopodium pollen season has cascading effects on daily functioning. Research consistently links allergic rhinitis-related sleep impairment to reduced academic performance in students, decreased workplace productivity in adults, and increased risk of motor vehicle accidents. For patients with moderate-to-severe congestion that disrupts sleep, addressing the nighttime symptom burden specifically — through HEPA bedroom filtration, evening nasal corticosteroid application, and potentially a bedtime antihistamine — can improve daytime functioning even before immunotherapy reaches full effectiveness.
Allergic asthma development
Persistent upper airway inflammation from untreated allergic rhinitis increases the risk of developing lower airway involvement (allergic asthma) over time.
Chronic sinusitis
Prolonged nasal mucosal inflammation and edema can obstruct sinus drainage, leading to bacterial superinfection and chronic sinusitis.
Sleep disruption and fatigue
Nasal congestion during fall pollen season impairs sleep quality, contributing to daytime fatigue, reduced concentration, and decreased productivity.
Causes and Exposure Sources
Chenopodium pollen exposure is nearly unavoidable for people who spend time outdoors during late summer and fall in temperate regions. The genus is cosmopolitan — found in every US state — and individual plants can produce millions of pollen grains. The lightweight, smooth-surfaced pollen is designed for efficient wind transport and can travel significant distances from the source plant.
Lamb's quarters, fat hen, white goosefoot
Chenopodium album
Quinoa (cultivated food crop)
Chenopodium quinoa
Wormseed, epazote (culinary herb)
Chenopodium ambrosioides
How it works
Chenopodium pollen allergy is a classic IgE-mediated Type I hypersensitivity reaction. Inhaled pollen grains deposit on nasal, conjunctival, and bronchial mucosa. Pollen proteins (Che a 1, Che a 2, Che a 3) are released, cross-link IgE antibodies on mast cell surfaces, and trigger degranulation with histamine, leukotriene, and prostaglandin release. This produces the immediate-phase response (sneezing, rhinorrhea, pruritus) within minutes, followed by a late-phase inflammatory response (nasal congestion, mucosal edema) hours later.
Exposure is highest in agricultural and suburban settings where disturbed soil provides ideal germination conditions. Gardens, field margins, roadsides, construction sites, and abandoned lots all support dense Chenopodium populations. Urban areas are not exempt — these weeds colonize any patch of disturbed ground.
The Amaranthaceae family includes several other important fall weed pollen allergens — Russian thistle/tumbleweed (Salsola kali), kochia/burning bush (Bassia scoparia), pigweed (Amaranthus), and saltbush (Atriplex). Extensive extract-level cross-reactivity exists across all these genera via shared profilins and polcalcins, meaning sensitization to one Amaranthaceae member often indicates reactivity to others.
The pollen production capacity of individual Chenopodium plants is remarkable. A single mature Chenopodium album plant can release millions of pollen grains over the course of its flowering period, and the lightweight, smooth-surfaced grains can remain airborne for hours under favorable wind conditions. Urban environments are not exempt from exposure — Chenopodium weeds colonize cracks in pavement, vacant lots, construction sites, and any patch of disturbed ground, bringing pollen production into close proximity with residential populations. Climate change projections suggest that rising CO2 levels and longer growing seasons will increase Chenopodium pollen production and extend the seasonal exposure window in temperate regions.
Risk factors to watch for
Residence in agricultural or suburban areas
Chenopodium weeds thrive in disturbed soil near gardens, farms, construction sites, and roadsides, creating high pollen exposure for nearby residents.
Family history of atopy
Individuals with a genetic predisposition to allergy (hay fever, asthma, eczema) are more likely to develop IgE sensitization to Chenopodium pollen.
Co-sensitization to other Amaranthaceae
Sensitization to Russian thistle, kochia, or pigweed increases the likelihood of concurrent Chenopodium reactivity through cross-reactive pan-allergens.
Outdoor occupation during fall season
Farmers, landscapers, and outdoor workers have elevated pollen exposure during the late summer through fall Chenopodium pollen season.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Goosefoot Allergy
Goosefoot pollen allergy is diagnosed through IgE-based allergy testing. Skin prick testing with Chenopodium extract and serum-specific IgE (ImmunoCAP) for Chenopodium are both available and well-validated. A positive result indicates IgE sensitization that, when correlated with fall-season symptoms, supports the diagnosis of clinically relevant Chenopodium pollen allergy. Component-resolved diagnostics can provide additional precision: Che a 1 (Ole e 1-like, 77 percent sensitization) is the primary marker for genuine Chenopodium sensitization, while Che a 2 (profilin) and Che a 3 (polcalcin) are pan-allergens whose positivity may reflect cross-reactivity from other pollen sources. Importantly, despite structural homology between Che a 1 and olive tree Ole e 1, their cross-reactivity is low and likely clinically irrelevant — co-sensitization more often represents true dual sensitization. At-home allergy testing services like Curex cover 40 or more common environmental allergens including weed pollens, with results in 5 days and insurance accepted, providing a convenient way to identify Chenopodium and other fall weed pollen sensitizations.
Skin Prick Test (Chenopodium Extract)
Standard skin prick testing with Chenopodium pollen extract detects IgE sensitization. Positive in approximately 9% of allergic populations in some studies. Quick in-office result.
Serum-Specific IgE (ImmunoCAP)
Blood-based measurement of Chenopodium-specific IgE antibodies. Available through clinical labs and at-home allergy testing services.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizCompare Treatment Options
See how different approaches stack up for managing your allergy symptoms long-term.
Traditional
Allergy Shots (SCIT)
Immunotherapy (SLIT)
RecommendedTreats root cause
Long-lasting relief
At-home treatment
No office visits
Low side effects
Estimated cost
Traditional
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Allergy Shots (SCIT)
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Immunotherapy (SLIT)
Recommended- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
The long-term solution to allergies
Instead of masking symptoms, immunotherapy retrains your immune system.
Goosefoot pollen allergy is an excellent candidate for allergen-specific immunotherapy because it is a well-characterized IgE-mediated aeroallergen with identified molecular allergens and extensive clinical evidence supporting immunotherapy efficacy for weed pollens. Both subcutaneous (SCIT) and sublingual (SLIT) immunotherapy approaches are effective. Sublingual immunotherapy drops, offered by providers like Curex starting at $39/month, allow daily at-home administration without weekly clinic visits. Custom formulations can target Chenopodium and other confirmed Amaranthaceae allergens. Clinical studies demonstrate 60 to 80 percent symptom reduction for weed pollen allergies, with benefits typically emerging within the first pollen season and sustained for years after completion of a 3 to 5 year course. Because extensive cross-reactivity exists within the Amaranthaceae family via shared profilins and polcalcins, treating Chenopodium sensitization may provide collateral benefit against related allergens like kochia and pigweed, though primary sensitizations to species-specific allergens (such as Sal k 1 from Russian thistle) may require separate targeting.
Confirm Chenopodium Sensitization
IgE testing confirms sensitization to Chenopodium pollen. Component testing for Che a 1 distinguishes primary sensitization from pan-allergen cross-reactivity.
Map Full Sensitization Profile
Test for concurrent fall allergens (ragweed, mugwort, Russian thistle) to create a comprehensive immunotherapy prescription.
Begin Sublingual Immunotherapy
Custom SLIT drops targeting confirmed Amaranthaceae and other fall weed allergens are administered daily under the tongue at home.
Monitor and Maintain
Track symptom improvement across fall seasons. Most patients notice meaningful relief within the first 6-12 months, with full benefit at 3-5 years.
“Clinical trials show 60-80% symptom reduction for weed pollen immunotherapy”
Treat your Goosefoot allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- 4.8/5Patient rating
- From $39/moWith insurance
- 50K+Patients treated
- HSA/FSAEligible
Living With Goosefoot Pollen Allergy
Goosefoot pollen allergy is a treatable condition with well-established management options. The fall season timing means the symptom burden is concentrated in a predictable window, allowing patients to plan medication and avoidance strategies in advance. Immunotherapy offers the possibility of long-term disease modification rather than lifelong symptomatic management.
Understanding Amaranthaceae Cross-Reactivity
If you are allergic to goosefoot pollen, you may also react to Russian thistle, kochia, and pigweed — all Amaranthaceae members with shared cross-reactive proteins. Discuss comprehensive Amaranthaceae testing with your allergist.
The Quinoa Question
Quinoa is a Chenopodium species, but food allergy to quinoa involves different proteins than pollen allergy to Chenopodium. Most patients with goosefoot pollen allergy can eat quinoa without problems. If you notice oral or gastrointestinal symptoms after quinoa, consult your allergist.
Planning for Fall Season
Start nasal corticosteroid sprays 1-2 weeks before your typical fall symptom onset for maximum effectiveness. Keep antihistamines readily available. If symptoms remain poorly controlled despite medications, discuss immunotherapy with your allergist.
Seasonal Patterns
July - August
medium intensity
September - October
high intensity
Prevention Tips
Monitor Fall Pollen Counts
Check local pollen forecasts during July through October. Chenopodium/Amaranthaceae pollen is reported as a combined category at most monitoring stations.
Keep Windows Closed During Peak Season
Use air conditioning with HEPA filtration rather than open windows during high fall weed pollen days.
Shower After Outdoor Activity
Washing hair and changing clothes after spending time outdoors removes pollen deposited on your body.
Manage Weeds on Your Property
Remove Chenopodium weeds from garden beds and disturbed soil before they flower and release pollen. The plants are easy to identify by their diamond-shaped leaves with mealy white coating.
Use HEPA Air Purifiers Indoors
Portable HEPA air purifiers in bedrooms reduce overnight pollen exposure, improving sleep quality during fall season.
Outlook for Goosefoot Allergy
The prognosis is favorable. Goosefoot pollen allergy responds well to standard pharmacotherapy and is an excellent candidate for immunotherapy. Patients who complete a 3 to 5 year immunotherapy course typically experience sustained symptom reduction even after treatment ends. Without immunotherapy, symptoms tend to persist year after year during the fall season but are well-controlled with antihistamines and nasal sprays in most patients.
Key takeaways
Goosefoot is a true IgE-mediated aeroallergen with well-characterized proteins (Che a 1, Che a 2, Che a 3)
Immunotherapy is directly indicated and typically achieves 60-80% symptom reduction
Extensive cross-reactivity within Amaranthaceae means testing for the full family is clinically valuable
Goosefoot allergy is systematically underdiagnosed because the pollen is counted alongside pigweed in standard monitoring reports and Chenopodium doesn't appear on many basic allergy panels. When I see a patient with late summer to fall symptoms that don't fully resolve after ragweed treatment, storage mite sensitization and goosefoot are the two allergens I add to the diagnostic workup — and.
Frequently Asked Questions
Goosefoot is the common name for the genus Chenopodium, while lamb's quarters specifically refers to the species Chenopodium album (also called fat hen or white goosefoot). Lamb's quarters is the most common and best-studied Chenopodium species, and the allergen data (Che a 1, Che a 2, Che a 3) comes from C. album research. The goosefoot page covers the genus-level overview; patients who know they react to C. album specifically may find the species-level page more targeted. If your symptoms are triggered specifically by C. album, your allergist may recommend component testing for Che a 1 to confirm primary sensitization.
Most patients with Chenopodium pollen allergy can eat quinoa without problems. Quinoa food allergy involves seed storage proteins different from the pollen allergens (Che a 1, Che a 2, Che a 3). Cross-reactivity between pollen and food allergens within Chenopodium has not been well-established. If you experience oral tingling, throat tightness, or gastrointestinal symptoms specifically after eating quinoa, discuss this with your allergist. If you develop oral symptoms after eating quinoa, formal food allergy testing can clarify whether quinoa seed proteins are involved.
Chenopodium and Amaranthus pollen grains are morphologically indistinguishable under standard light microscopy — they are nearly identical in size, shape, and surface texture. Most aerobiology counting stations report them as a combined Chenopodiaceae/Amaranthaceae or Cheno/Am category rather than separating the two genera. This complicates species-specific pollen monitoring but does not meaningfully affect clinical management, since the diagnostic and treatment approach is essentially identical for all Amaranthaceae pollen allergies. Molecular methods can distinguish genera but are not used in routine pollen counting.
Despite structural homology between Che a 1 (Chenopodium's major allergen) and Ole e 1 (olive's major allergen), their clinical cross-reactivity is low and likely irrelevant for most patients. Published research suggests that patients who test positive to both Chenopodium and olive are experiencing genuine dual sensitization — two independent immune responses to structurally similar but antigenically distinct proteins — rather than one allergy cross-reacting through shared epitopes. Component-resolved diagnostics measuring Che a 1 alongside Ole e 1 can clarify the pattern for individual patients who present with both positivities.
Chenopodium pollen season spans late summer through fall, typically July through October in temperate US regions. Peak pollen production generally occurs in August and September across most of the country, coinciding with ragweed season. In some western regions with hot dry summers, Chenopodium may start pollinating as early as June. Patients with both Chenopodium and ragweed sensitization experience the heaviest and most prolonged symptom burden during this overlap period from August through October. Patients with both Chenopodium and ragweed sensitization may benefit from immunotherapy formulations that include both allergen sources to address the full symptom burden.
Yes. Goosefoot pollen allergy is an excellent candidate for allergen-specific immunotherapy because it is a well-characterized IgE-mediated allergy with identified molecular allergens (Che a 1, Che a 2, Che a 3). Both subcutaneous immunotherapy (allergy shots) and sublingual immunotherapy (drops under the tongue) are effective for weed pollen desensitization, with clinical trials consistently showing 60 to 80 percent long-term symptom reduction. The treatment is typically formulated to address the full Amaranthaceae family sensitization profile alongside any co-existing ragweed or grass pollen allergies.
The Chenopodium genus encompasses approximately 150 species distributed worldwide, with the greatest diversity in temperate regions of North and South America, Europe, and Central Asia. Lamb's quarters (C. album) is the most cosmopolitan species and the one for which allergen data is most thoroughly documented. Other species with regional importance include C. murale (nettle-leaved goosefoot), C. ambrosioides (epazote, which is also a culinary herb), and C. quinoa (the cultivated grain crop). In most US locations, C. album is the primary clinically relevant Chenopodium allergen source.
Yes. Spinach (Spinacia oleracea) and beets (Beta vulgaris) are both members of the Amaranthaceae family (formerly Chenopodiaceae), placing them in the same broad family as Chenopodium goosefoot. These culinary crops are botanical relatives of the weedy goosefoots. However, food allergy to spinach or beets is not directly linked to Chenopodium pollen allergy. The pollen allergens (Che a 1, Che a 2, Che a 3) are structurally distinct from the storage proteins in spinach or beet seeds, and no established pollen-food allergy syndrome connecting goosefoot pollen to these vegetables has been documented.
Medical References
- [1]Villalba M, Barderas R, Mas S, et al. Amaranthaceae pollens: Review of an emerging allergy in the Mediterranean area. J Investig Allergol Clin Immunol 2014;24(6):371-381.
- [2]Barderas R, Villalba M, Pascual CY, et al. Profilin (Che a 2) and polcalcin (Che a 3) are relevant allergens of Chenopodium album pollen. J Allergy Clin Immunol 2004;113(6):1192-1198.
- [3]Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy 2012;67(1):18-24.
- [4]AAAAI/ACAAI Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011;127(1 Suppl):S1-55.
- [5]Larenas-Linnemann D, Michels A, Ackermann-Simon J, et al. Allergen sensitization linked to climate change in the United States. Ann Allergy Asthma Immunol 2020;125(3):258-268.
- [6]ACAAI (American College of Allergy, Asthma, and Immunology). Allergy Testing Practice Parameters. Ann Allergy Asthma Immunol 2008.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Goosefoot allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
